top of page

ANAVEX New Website - Untitled Page.png

Search

- May 21, 2017

Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders

Antiepileptic Drug Trials XIV 2017 Conference in Aventura, Florida on May 19th, 2017.

View Presentation

Recent Posts

Anavex Life Sciences Announces Exceeding of Enrollment Target for ANAVEX®2-73 (blarcamesine)

Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on February 7, 2023

Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial

bottom of page